Jain Global LLC Acadia Pharmaceuticals Inc Transaction History
Jain Global LLC
- $11.9 Billion
- Q2 2025
A detailed history of Jain Global LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Jain Global LLC holds 22,156 shares of ACAD stock, worth $525,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,156
Previous 14,359
54.3%
Holding current value
$525,540
Previous $238,000
100.42%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACAD
# of Institutions
355Shares Held
164MCall Options Held
751KPut Options Held
274K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.02 Billion9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$360 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$286 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$213 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$147 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.84B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...